| Name | Title | Contact Details |
|---|
Synapse Medical Communications is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New York, NY. To find more information about Synapse Medical Communications, please visit www.synapseny.com
ShapeUp is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Providence, RI. To find more information about ShapeUp, please visit www.shapeup.com
Openfit is the place to go to get results and have fun doing it – an all-new digital streaming platform that integrates fitness, nutrition, and wellness together in one place. We offer world-class fitness programs with workouts designed to reach any goal, perfectly paired nutrition plans, safe and effective supplements, and customized wellness advice. In the process, we`ve searched far and wide to bring together the world`s foremost fitness and nutrition experts to make sure you succeed in reaching your goals. Whether you`re training for an extreme event, looking to lose weight, or just wanting to live each day a little healthier than the last – you`ll not only find solutions at Openfit, you`ll find inspiration. The kind that powers you through your workout and leaves you feeling pumped to do it again tomorrow. So you can reach your goals…and want to come back for more. That`s the simplicity of living a healthy, vibrant life – in your own way – every day. We hope you`ll come live yours at Openfit.
Mission Internal Medical Group Incorporated is a Laguna Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.